Latest News

Clade I mpox emergence reveals structural collapse in U.S. disease surveillance and public health response infrastructure.

RFK Jr's dismantling of CDC scientific leadership replaces expertise with anti-vaccine ideology and predetermined policy conclusions.

Deteriorating public health surveillance capacity creates blind spots for emerging disease threats and health disparities.

Elimination of surveillance funding creates blind spots in disease tracking and health equity measurement.

CDC progress data on STI and overdose prevention initiatives shows mixed results.

Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.

Call to action for community input on federal health policy initiatives.

CDC doxycycline post-exposure prophylaxis guidance for STI prevention amid political debate.

Mpox emergency response analysis and lessons for future equitable public health crises.

Q4 2023 Watch: Bipartisan PEPFAR reauthorization push; ADAP coverage and Medicaid updates tracked.

CDC data shows declining health ratings, increased mental health needs, and housing insecurity among PLWH.

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

CDC report: HCV persists despite decade-old cure due to payer barriers and screening failures.

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

State-level MPV surveillance: Black Americans overrepresented in Southern states amid reporting gaps.

US monkeypox response: 31% of cases among Black persons, vaccine distribution equity concerns persist.

2020 CDC HIV surveillance reveals COVID-19's impact on HIV prevention and testing with decreased diagnoses and increased deaths.

Pediatric hepatitis investigations lack typical viruses but show adenovirus and potential COVID-19 involvement.

STI and HCV rates rise despite reduced screening, reflecting chronic public health underfunding.

CDC updates STI treatment guidelines; ACIP recommends universal adult HBV vaccination and HPV catch-up.